Sebi has imposed penalties totalling ₹33.08 crore on Varanium Cloud, promoter Harshawardhan Sabale and seven others over alleged financial misrepresentation and diversion of IPO and rights issue proceeds. The regulator has also barred Varanium Cloud and Sabale from the securities…
Honasa Consumer has called off its proposed acquisition of a 58% stake in Fluence Pharma after the closing conditions under the share purchase agreement were not fulfilled. The FMCG company said it will continue to evaluate organic and inorganic opportunities…
The government had budgeted an ₹80,000 crore fundraise from disinvestments in FY27. A successful 6% stake sale in Hindustan Copper will leave around ₹24,303 crore to be raised over the remaining seven months of this financial year.
The RBI turned a net dollar buyer in June, purchasing $561 million from the forex market after selling $6 billion in May. The shift comes as capital inflows surged following the central bank’s policy measures, helping steady the rupee after…
Sai Parenterals has strengthened its Australian OTC business with a fresh AU$30 million three-year supply agreement, taking its total contracted OTC supply commitments in the country to AU$232 million, or about ₹1,506 crore. The latest renewal follows a larger AU$202…
The nearly 75-point gain during the CAS helped the Nifty engulf the moves of the previous three sessions. The index also reclaimed its 20-day DEMA, placed around 24,300.
US economic data, Iran war support, oil prices, and bond market trends are key. Durable Goods, GDP, PCE, and consumer spending data are due. US support for Iran war fell to 31%. Oil prices dropped ove
The PepsiCo bottler will set up a wholly-owned subsidiary for ready-to-drink alcoholic beverages and has hired former Diageo executive Prathmesh Mishra to lead the new business.
Gold has climbed to its highest level since May as US fiscal concerns and Treasury market pressures revive the dollar-debasement trade. But while the macro backdrop remains supportive, a large GLD options trade shows at least one investor positioning for…
The US drug regulator issued seven observations after an eight-day inspection of Cipla’s Pithampur facility. The company said it will respond within the stipulated timeline.